Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Microvesicles: novel biomarkers for neurological disorders.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
FDA warns about seizures linked to MS drug
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
The little compound that could: how phenytoin changed drug discovery and development.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Gilenya prescribing information
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Rituximab: Don't Count It Out as MS Treatment
Reproductive issues in women with multiple sclerosis: ethical considerations.
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Neuromyelitis Optica Following Human Papillomavirus Vaccination.

Pages